45-1 Ramsey Road
About Creative Biolabs
Creative Biolabs is the leading custom service provider that has extensive experience in various antibody production and engineering fields. Our service portfolio includes mouse and rat monoclonal antibody production using hybridoma technology, human, monkey, rabbit, chicken, dog, llama and camel monoclonal antibody production using various antibody library technologies. We are also professional in conducting in depth antibody humanization and affinity maturation using phage display and DNA mutagenesis approaches. In addition, OEM services for bulk scale engineering antibody manufacturing. We believe to build up a custom-service-centered business model is important for optimizing the drug development process, leveraging accessible resources, and forming a team of various background to conduct drug discovery in future. Our commitment to this long-term goal motivates us to deliver the highest quality results to our clients with speed.
Creative Biolabs is specialized in providing custom biotechnology and pharmaceutical services that cover the full scope of biotechnology needs of early drug discovery and development. As a trusted provider of the most cost-effective outsourcing solutions, Creative Biolabs has been working for a large number of satisfied clients from biotechnology and pharmaceutical companies as well as government and academic research laboratories all over the world.
Visit our YouTube channel here
21 articles with Creative Biolabs
Enzolytics Announces the Signing of a Letter of Intent with Creative Biolabs, Inc. for Licensing and Commercialization of anti-HTLV-1 Monoclonal Antibodies
Enzolytics, Inc. announces the signing of a Letter of Intent (LOI) with Creative Biolabs to complete the joint production and commercialization of HTLV-1 monoclonal antibodies by combining the technologies of the companies.
Booming Breakthrough: Creative Biolabs Enables World’s First 100% Identification of Leucine and Isoleucine in De Novo Antibody Sequencing
It has long been a worldwide problem to precisely identify leucine and isoleucine, not to mention 100% accuracy.
With more than ten years of experience in serving clinical researches and academic researches, Creative Biolabs developed bispecific t cell engager for cancer treatment and immune regulation researches.
With the common effort of its scientists, Creative Biolabs successfully developed antibody affinity maturation service for antibody affinity maturation improvement.
To assist researchers further, scientists from Creative Biolabs successfully updated its Native Shark Antibody Discovery Service recently.
Creative Biolabs Can Help Reduce Immunogenicity While Remaining the Affinity With Humanized Antibody Germinalization
Creative Biolabs has successfully developed GHA platform to germinalize humanized antibody production.
Creative Biolabs Is About To Stop Accepting New Applications For Fall 2017 Creative Biolabs Scholarship Program
Creative Biolabs Launches Various Bispecific Antibodies And Related Services To Increase The Efficacy Of Current Therapeutic Antibodies
Creative Biolabs Released Native Antibody Discovery Service To Conquer The Shortcomings Of In Vitro Antibody Display Methods